TP53 and COVID-19: Furthermore, in agreement with our research, in a transcriptomic study, in addition to apoptosis, the p53 signaling pathway was highly enriched in PBMCs of the COVID-19 group and may be associated with lymphopenia in COVID-19 patients (97).